Antithrombin in burn trauma

Intensive Care Medicine: Annual Update 2007

Volumn , Issue , 2007, Pages 791-796

  Enkhbaatar, P ^a   Traber, L D ^a   Traber, D L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891973055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-49518-7_71     Document Type: Chapter

References (31)

1. Barrow RE, Spies M, Barrow LN, Herndon DN (2004) Influence of demographics and inhalation injury on burn mortality in children. Burns 30:72-77
2. Enkhbaatar P, Murakami K, Shimoda K, et al (2003) The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 167:1021-1026
3. Kowal-Vern A, Walenga JM, McGill V, Gameli RL (2001) The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injury. Burns 27: 52-60
4. Kowal-Vern A, McGill V, Walenga JM, Gameli RL (2000) Antithrombin HI concentrate in the acute phase of thermal injury. Burns 26:97-101
5. Garcia-Avello A, Lorente JA, Cesar-Perez J, et al (1998) Hypercoagulability and hyperfibrinoly-sis is related to organ failure and prognosis after burn trauma. Thromb Res 89:59-64
6. Olson ST, Bjork I, Shore JD (1993) Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol 222:525-559
7. Olson ST, Bjork I (1991) Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J Biol Chem 266:6353-6364
8. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J (1992) Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267:12528-12538
9. Justus AC, Roussev R, Norcross JL, Faulk WP (1995) Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin. Thromb Res 79:175-186
10. Wu YI, Sheffield WP, Blajchman MA (1994) Defining the heparin-binding domain of anti-thrombin. Blood Coagul Fibrinolysis 5:83-95
11. Swedenborg J (1998) The mechanisms of action of alpha-and beta-isoforms of antithrombin. Blood Coagul Fibrinolysis 9-.S7-S10
12. Becker BF, Heindl B, Kupatt C, Zahler S (2000) Endothelial function and hemostasis. Z Kar-diol 89:160-167
13. Senden NH, Jeunhomme TM, Heemskerk JW, et al (1998) Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 161:4318-4324
14. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96: 11023
15. Coughlin SR (2001) Protease-activated receptors in vascular biology. Thromb Haemost 86: 298-307
16. Esmon C (2000) The protein C pathway. Crit Care Med 28:S44-S48
17. Liu J, Schuff-Werner P, Steiner M (2006) Thrombin/thrombin receptor (PAR-l)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Com-mun 343:183-189
18. Okajima K, Uchiba M (1998) The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost 24:27-32
19. Souter, PJ, Thomas S, Hubbard AR, et al (2001) Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med. 29:134-139
20. Kaneider NC, Egger P, Dunzendorfer S, Wiedermann C (2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun 287:42-46
21. Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL (2001) Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 280:L1233-L1241
22. Enkhbaatar P, Traber DL (2004) Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 107:137-143
23. Aoki K, Aikawa N, Sekine K, et al (2001) Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Burns 27:569-575
24. Enkhbaatar P, Murakami K, Cox R, et al (2004) Aerosolized tissue plasminogen activator improves pulmonary function in sheep with burn and smoke inhalation. Shock 22:70-75
25. Murakami K, McGuire R, Cox RA, et al (2003) Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 31: 577-583
26. Murakami K, Enkhbaatar P, Shimoda K, et al (2003) High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep. Clin Sci (Lond) 104:349-356
27. Enkhbaatar P, Murakami K, Westphal M, et al (2004) Combined antithrombin and heparin nebulization improves pulmonary function in sheep with burn and smoke inhalation Crit Care Med 32:A24 (abst)
28. Enkhbaatar P, Traber L, Nakano Y, et al (2006) Effects of intravenously administered recombinant human antithrombin (rhAT) and aerosolized heparin on burn and smoke inhalation-induced acute lung injury. XIII Congress of the International Society for Burn Injuries, p 216 (abst)
29. Murakami K, McGuire R, Cox RA, et al (2002) Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 18:236-241
30. Warren B, Eid A, Singer P, et al (2001) High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 286:1869-1878
31. Wiedermann CJ, Hoffmann JN, Juers M, et al (2006) High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety. Crit Care Med 34:285-292